1. Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9
    Carlota Oleaga et al, 2021, Journal of Lipid Research CrossRef
  2. Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar
    Dalal Al‐Sharshani et al, 2023, Molecular Genetics & Genomic Medicine CrossRef
  3. ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice
    Lakshini Weerasekera et al, 2017, Mediators of Inflammation CrossRef
  4. Loss of Furin in β-Cells Induces an mTORC1-ATF4 Anabolic Pathway That Leads to β-Cell Dysfunction
    Bas Brouwers et al, 2021, Diabetes CrossRef
  5. Functional polymorphisms of the APOA1/C3/A4/A5-ZPR1-BUD13 gene cluster are associated with dyslipidemia in a sex-specific pattern
    Wei Bai et al, 2019, PeerJ CrossRef
  6. FURIN Promoter Methylation Predicts the Risk of Incident Diabetes: A Prospective Analysis in the Gusu Cohort
    Yan He et al, 2022, Frontiers in Endocrinology CrossRef
  7. An Overview of the Role of Furin in Type 2 Diabetes
    Sulaiman K. Marafie et al, 2023, Cells CrossRef
  8. The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples
    Sophia Harlid et al, 2017, Mediators of Inflammation CrossRef
  9. Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry
    Georgia Ragia et al, 2020, Pharmacogenomics CrossRef
  10. Impact of Diabetes in Patients Diagnosed With COVID-19
    Mohamed Abu-Farha et al, 2020, Frontiers in Immunology CrossRef
  11. Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality
    C. Fernandez et al, 2018, Journal of Internal Medicine CrossRef
  12. Mouse Models of Human Proprotein Convertase Insufficiency
    Manita Shakya et al, 2021, Endocrine Reviews CrossRef
  13. Association Between Serum Furin and Fasting Glucose: A Cross-Sectional Study in Chinese Adults
    Yan He et al, 2022, Frontiers in Endocrinology CrossRef
  14. Identification of three genetic variants as novel susceptibility loci for body mass index in a Japanese population
    Yoshiki Yasukochi et al, 2018, Physiological Genomics CrossRef
  15. The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9
    Nabil G. Seidah et al, 2017, Pharmacological Reviews CrossRef
  16. Association between Genetic Variants of CELSR2-PSRC1-SORT1 and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
    Rosa Giannina Castillo-Avila et al, 2023, Journal of Cardiovascular Development and Disease CrossRef
  17. Genome-Wide Identification of Rare and Common Variants Driving Triglyceride Levels in a Nevada Population
    Robert W. Read et al, 2021, Frontiers in Genetics CrossRef
  18. A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes
    Chiara Zusi et al, 2018, Diabetes Research and Clinical Practice CrossRef
  19. Pediatric Non‐Alcoholic Fatty Liver Disease Is Affected by Genetic Variants Involved in Lifespan/Healthspan
    Annalisa Crudele et al, 2021, Journal of Pediatric Gastroenterology and Nutrition CrossRef
  20. The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia
    Martine Paquette et al, 2020, Journal of Clinical Lipidology CrossRef
  21. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification
    Vince Kornél Grolmusz et al, 2021, Frontiers in Immunology CrossRef
  22. Effect of FURIN SNP rs17514846 on coronary atherosclerosis in human cardiac specimens: An autopsy study of 106 cases
    Gentaro Yamasaki et al, 2022, Legal Medicine CrossRef